Which type of exposure is used to assess carcinogenicity and teratogenicity?

Prepare for the Adverse Effects and Toxicology Test with our comprehensive format. Utilize flashcards and multiple-choice questions, complete with hints and explanations to ace your exam!

Multiple Choice

Which type of exposure is used to assess carcinogenicity and teratogenicity?

Explanation:
Long-term, or chronic, exposure is needed because cancer and developmental defects are time-dependent outcomes that typically don’t appear after a single short exposure. Carcinogenic effects require sufficient cumulative dose over extended periods for tumors to develop, as cancer involves gradual processes like DNA damage accumulation, mutation fixation, and clonal expansion that unfold over months to years. Teratogenic effects depend on exposure during specific windows of fetal development; providing ongoing exposure across gestation increases the likelihood of hitting those critical periods and revealing malformations or growth issues. In contrast, an acute exposure might show immediate toxicity but is unlikely to reveal cancer risk or developmental abnormalities that require sustained exposure. Intermittent exposure also risks missing the relevant windows and cumulative dose needed to detect these outcomes.

Long-term, or chronic, exposure is needed because cancer and developmental defects are time-dependent outcomes that typically don’t appear after a single short exposure. Carcinogenic effects require sufficient cumulative dose over extended periods for tumors to develop, as cancer involves gradual processes like DNA damage accumulation, mutation fixation, and clonal expansion that unfold over months to years. Teratogenic effects depend on exposure during specific windows of fetal development; providing ongoing exposure across gestation increases the likelihood of hitting those critical periods and revealing malformations or growth issues.

In contrast, an acute exposure might show immediate toxicity but is unlikely to reveal cancer risk or developmental abnormalities that require sustained exposure. Intermittent exposure also risks missing the relevant windows and cumulative dose needed to detect these outcomes.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy